FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048571170> ?p ?o ?g. }

• W3048571170 abstract "We evaluate whether the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 (PPARγ2) has a role in the progression of diabetes by modulating the occurrence of treatment failure to glucose-lowering drugs.We studied 215 patients with type 2 diabetes participating in the Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents Intervention Trial study. All participants were insufficiently controlled (glycated haemoglobin [HbA1c ] 7.0%-9.0%) with metformin 2 g/day and were randomly allocated to add-on pioglitazone or a sulfonylurea. Treatment failure was defined as HbA1c ≥8% on two consecutive visits, 3 months apart.Carriers or non-carriers of the polymorphism had similar age, body mass index, and diabetes duration. Ala carriers had lower fasting plasma insulin, better insulin sensitivity (Homeostasis Model Assessment [HOMA]2-%S), and worse beta cell secretion (HOMA2-%B) than non-carriers. During 24 months of follow-up, 32.5% among the Ala carriers and 8.6% among non-carriers (P < 0.001) developed treatment failure with a cumulative incidence of 18.6 vs 4.6/100 person-years. Those patients who developed treatment failure were older, had a younger age at diabetes diagnosis (48 ± 10 vs 52 ± 7 years; P = 0.032), higher HbA1c (8.1 ± 0.5 vs 7.7 ± 0.5%; P < 0.001), and lower HOMA2-%B (30 ± 12 vs 46 ± 29; P = 0.015) at study entry, as compared to those who did not develop treatment failure. At multivariate analysis, the Pro12Ala polymorphism was significantly associated with treatment failure (hazard ratio [HR] 4.45; 95% confidence interval [CI] 1.79-11.1; P < 0.001); HbA1c at study entry was the other independent predictor of failure in this study population.The Pro12Ala polymorphism is associated with a greater insulin sensitivity, reduced beta cell function and a substantially increased risk of treatment failure." @default.
• W3048571170 created "2020-08-18" @default.
• W3048571170 creator A5001056979 @default.
• W3048571170 creator A5003724609 @default.
• W3048571170 creator A5004072258 @default.
• W3048571170 creator A5034305652 @default.
• W3048571170 creator A5041306496 @default.
• W3048571170 creator A5045293648 @default.
• W3048571170 creator A5062445008 @default.
• W3048571170 creator A5064556745 @default.
• W3048571170 creator A5067759067 @default.
• W3048571170 creator A5068562700 @default.
• W3048571170 creator A5071968372 @default.
• W3048571170 creator A5091084171 @default.
• W3048571170 date "2020-09-02" @default.
• W3048571170 modified "2023-09-23" @default.
• W3048571170 title "The Pro12Ala polymorphism of PPARγ2 modulates beta cell function and failure to oral glucose‐lowering drugs in patients with type 2 diabetes" @default.
• W3048571170 cites W1966764711 @default.
• W3048571170 cites W1975588287 @default.
• W3048571170 cites W1996441843 @default.
• W3048571170 cites W2019405117 @default.
• W3048571170 cites W2066898102 @default.
• W3048571170 cites W2068112581 @default.
• W3048571170 cites W2070101660 @default.
• W3048571170 cites W2072199247 @default.
• W3048571170 cites W2100271953 @default.
• W3048571170 cites W2101515997 @default.
• W3048571170 cites W2103930636 @default.
• W3048571170 cites W2104855782 @default.
• W3048571170 cites W2105026884 @default.
• W3048571170 cites W2106669194 @default.
• W3048571170 cites W2111223640 @default.
• W3048571170 cites W2111473023 @default.
• W3048571170 cites W2170932033 @default.
• W3048571170 cites W2171294019 @default.
• W3048571170 cites W2755083612 @default.
• W3048571170 cites W2783296927 @default.
• W3048571170 cites W2791469895 @default.
• W3048571170 cites W2808151096 @default.
• W3048571170 cites W2902225118 @default.
• W3048571170 cites W2942642824 @default.
• W3048571170 cites W2994642993 @default.
• W3048571170 doi "https://doi.org/10.1002/dmrr.3392" @default.
• W3048571170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32783395" @default.
• W3048571170 hasPublicationYear "2020" @default.
• W3048571170 type Work @default.
• W3048571170 sameAs 3048571170 @default.
• W3048571170 citedByCount "1" @default.
• W3048571170 countsByYear W30485711702022 @default.
• W3048571170 crossrefType "journal-article" @default.
• W3048571170 hasAuthorship W3048571170A5001056979 @default.
• W3048571170 hasAuthorship W3048571170A5003724609 @default.
• W3048571170 hasAuthorship W3048571170A5004072258 @default.
• W3048571170 hasAuthorship W3048571170A5034305652 @default.
• W3048571170 hasAuthorship W3048571170A5041306496 @default.
• W3048571170 hasAuthorship W3048571170A5045293648 @default.
• W3048571170 hasAuthorship W3048571170A5062445008 @default.
• W3048571170 hasAuthorship W3048571170A5064556745 @default.
• W3048571170 hasAuthorship W3048571170A5067759067 @default.
• W3048571170 hasAuthorship W3048571170A5068562700 @default.
• W3048571170 hasAuthorship W3048571170A5071968372 @default.
• W3048571170 hasAuthorship W3048571170A5091084171 @default.
• W3048571170 hasConcept C126322002 @default.
• W3048571170 hasConcept C134018914 @default.
• W3048571170 hasConcept C207103383 @default.
• W3048571170 hasConcept C2777180221 @default.
• W3048571170 hasConcept C2777391703 @default.
• W3048571170 hasConcept C2778384471 @default.
• W3048571170 hasConcept C2779306644 @default.
• W3048571170 hasConcept C2780152017 @default.
• W3048571170 hasConcept C2780221984 @default.
• W3048571170 hasConcept C2780323712 @default.
• W3048571170 hasConcept C44249647 @default.
• W3048571170 hasConcept C555293320 @default.
• W3048571170 hasConcept C71924100 @default.
• W3048571170 hasConceptScore W3048571170C126322002 @default.
• W3048571170 hasConceptScore W3048571170C134018914 @default.
• W3048571170 hasConceptScore W3048571170C207103383 @default.
• W3048571170 hasConceptScore W3048571170C2777180221 @default.
• W3048571170 hasConceptScore W3048571170C2777391703 @default.
• W3048571170 hasConceptScore W3048571170C2778384471 @default.
• W3048571170 hasConceptScore W3048571170C2779306644 @default.
• W3048571170 hasConceptScore W3048571170C2780152017 @default.
• W3048571170 hasConceptScore W3048571170C2780221984 @default.
• W3048571170 hasConceptScore W3048571170C2780323712 @default.
• W3048571170 hasConceptScore W3048571170C44249647 @default.
• W3048571170 hasConceptScore W3048571170C555293320 @default.
• W3048571170 hasConceptScore W3048571170C71924100 @default.
• W3048571170 hasFunder F4320334846 @default.
• W3048571170 hasIssue "3" @default.
• W3048571170 hasLocation W30485711701 @default.
• W3048571170 hasLocation W30485711702 @default.
• W3048571170 hasOpenAccess W3048571170 @default.
• W3048571170 hasPrimaryLocation W30485711701 @default.
• W3048571170 hasRelatedWork W138803513 @default.
• W3048571170 hasRelatedWork W1979397173 @default.
• W3048571170 hasRelatedWork W1986132654 @default.
• W3048571170 hasRelatedWork W1998227193 @default.
• W3048571170 hasRelatedWork W2082140668 @default.
• W3048571170 hasRelatedWork W2083147531 @default.

• next